Inselspital, Bern University Hospital / University Cancer Center Inselspital
Bern's university hospital, a high-volume radioligand therapy centre and home to the Bern Center for Precision Medicine and the SAKK trial group.
Overview
The University Cancer Center Inselspital coordinates cancer care at Switzerland's capital university hospital. Its nuclear medicine department under Axel Rominger is one of Europe's largest PSMA and somatostatin-receptor radioligand therapy centres with a strong dosimetry programme, and Mark Rubin, co-discoverer of the TMPRSS2-ERG fusion in prostate cancer, directs the Department for BioMedical Research and the Bern Center for Precision Medicine. The hospital runs neuro-oncology and neurosurgery, thoracic and gastrointestinal surgery, haematology and CAR-T, and is a lead site for the Swiss Group for Clinical Cancer Research (SAKK), whose coordinating centre is in Bern. The Insel Gruppe covers a large catchment across the Bernese region.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to University Hospital of Bern, including child institutions. 406 works · 4,165 citations · 87% open access · 11% clinical trials · 3% reviews.
- Thomas Pabst41 works
- Michael Daskalakis35 works
- Ulrike Bacher35 works
- Urban Novak27 works
- Beat Gloor24 works
- Katja Seipel20 works
- Gerald Georg Wulf18 works
- Pauline Aeschbacher18 works
- Martin D. Berger18 works
- Anna Maria Sureda17 works
- Radioligand therapy and dosimetry
- Bern Center for Precision Medicine
- Prostate cancer genomics
- Neuro-oncology
- SAKK trials
Similar pages
not linked directly; found by shared links- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Dosimetry, Theranostics, Somatostatin receptor 2, Lutetium-177 dotatate.
- InstitutionErasmus MC Cancer Institute
Shares Glioma & glioblastoma, Theranostics, Somatostatin receptor 2, Lutetium-177 dotatate.
- InstitutionUppsala University Hospital / Uppsala University
Shares Glioma & glioblastoma, Somatostatin receptor 2, Lutetium-177 dotatate, Neuroendocrine tumours.
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours.
- PersonRahul Aggarwal
Shares PSMA, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).
- InstitutionWest German Cancer Center (WTZ), University Hospital Essen
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET.
- CompanyPOINT Biopharma
Shares Somatostatin receptor 2, PSMA, Neuroendocrine tumours, Radioligand therapy (beta emitters).
- PersonJohannes Czernin
Shares PSMA, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).